Clinical treatment and prognosis of childhood hypertrophic obstructive cardiomyopathy

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100048166

Enrollment

Unknown

Registered

2021-07-04

Start date

2021-07-15

Completion date

Unknown

Last updated

2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children with third degree atrioventricular block

Interventions

Case series:No

Eligibility

Sex/Gender

All

Age

No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. Age <18 years; 2. Children with hypertrophic obstructive cardiomyopathy caused by various reasons; 3. Parents agree to clinical treatment.

Exclusion criteria

Exclusion criteria: No.

Design outcomes

Primary

Measure	Time frame
prognostic effect;	—

Countries

China

Contacts

Public ContactZhou Gengxu

Department of Pediatric, Chinese PLA General Hospital

cardiacsurgeon@126.com+86 15001395415

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026